AMNEAL PHARMACEUTICALS, INC. group: subsidiaries and structure
Corporation · WILMINGTON, United States · LEI 549300VV176ZO5WQHZ61
4subsidiaries
2countries
1held directly
1lapsed LEIs
2links on accounts older than 24 months
0ISINs of subsidiaries
Summary
AMNEAL PHARMACEUTICALS, INC. is the ultimate parent of 4 subsidiaries with LEIs in 2 countries, as reported to GLEIF. 1 is held directly; the others sit below intermediate companies. The largest numbers are in India (3) and in the United States (1). 1 of the subsidiaries has a lapsed LEI, and 2 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 3 ISINs for the parent and 0 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 8 Mar 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
2 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| AMNEAL ONCOLOGY PRIVATE LIMITED | India | AHMEDABAD | 335800MVPWWOVDTLD233 | 2024 | |
| AMNEAL PHARMACEUTICALS PRIVATE LIMITED | India | AHMEDABAD | 33580046CGWFAEQZQU58 | 2024 | |
| RAKS PHARMA PRIVATE LIMITED | India | AHMEDABAD | 335800U8DSW2KF6GB194 | 2023 | > 24 months |
| AMNEAL PHARMACEUTICALS LLC | United States | WILMINGTON | 54930037VIXE7LRZ1M66 | 2018 | lapsed > 24 months |